版本:
中国

BRIEF-Enanta Pharmaceuticals reports Q2 loss per share $0.28

May 8 Enanta Pharmaceuticals Inc

* Enanta Pharmaceuticals reports financial results for its fiscal second quarter ended March 31, 2017

* Q2 loss per share $0.28

* Q2 revenue $9.0 million versus I/B/E/S view $9.2 million

* Q2 earnings per share view $-0.38 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐